Copyright
©The Author(s) 2021.
World J Clin Cases. Oct 6, 2021; 9(28): 8349-8357
Published online Oct 6, 2021. doi: 10.12998/wjcc.v9.i28.8349
Published online Oct 6, 2021. doi: 10.12998/wjcc.v9.i28.8349
Table 4 Comparison of uterine artery blood flow parameters between the two groups (n = 65, mean ± SD)
| Group | PSV (cm/s) | EDV (cm/s) | RI | |||
| Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | |
| Fenmatong group | 30.85 ± 3.14 | 35.42 ± 3.36 | 5.24 ± 1.14 | 12.19 ± 1.45 | 0.87 ± 0.10 | 0.81 ± 0.08 |
| Observation group | 30.41 ± 3.52 | 38.96 ± 3.11 | 5.30 ± 1.07 | 15.89 ± 1.57 | 0.86 ± 0.13 | 0.73 ± 0.10 |
| t | 0.752 | 6.234 | 0.309 | 13.958 | 0.492 | 5.036 |
| P value | 0.453 | 0.000 | 0.758 | 0.000 | 0.624 | 0.000 |
- Citation: Lin XM, Chen M, Wang QL, Ye XM, Chen HF. Clinical observation of Kuntai capsule combined with Fenmotong in treatment of decline of ovarian reserve function. World J Clin Cases 2021; 9(28): 8349-8357
- URL: https://www.wjgnet.com/2307-8960/full/v9/i28/8349.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i28.8349